NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Echelon Corporation
(NASDAQ:ELON), NII Holdings, Inc. (NASDAQ:NIHD), ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Zion Oil & Gas, Inc. (NASDAQ:ZN), vTv
Therapeutics Inc. (NASDASQ:VTVT), and Sears Holdings Corporation (NASDAQ:SHLD) including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ELON DOWNLOAD: http://Fundamental-Markets.com/register/?so=ELON
NIHD DOWNLOAD: http://Fundamental-Markets.com/register/?so=NIHD
ANIP DOWNLOAD: http://Fundamental-Markets.com/register/?so=ANIP
ZN DOWNLOAD: http://Fundamental-Markets.com/register/?so=ZN
VTVT DOWNLOAD: http://Fundamental-Markets.com/register/?so=VTVT
SHLD DOWNLOAD: http://Fundamental-Markets.com/register/?so=SHLD
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Echelon Corporation (NASDAQ:ELON), NII Holdings, Inc. (NASDAQ:NIHD), ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Zion Oil & Gas, Inc.
(NASDAQ:ZN), vTv Therapeutics Inc. (NASDASQ:VTVT), and Sears Holdings Corporation (NASDAQ:SHLD) on a fundamental level and outlines
the overall demand for their products and services in addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s
readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. All information in this
release was accessed November 1, 2017. Please download the entire research report, free of charge, to ensure you are reading all
relevant material information. All amounts in millions (except per share amounts).
-----------------------------------------
ECHELON CORPORATION (ELON) REPORT OVERVIEW
Echelon's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Echelon reported revenue of $8.0 vs $8.1 (down 1.2%),
diluted earnings per share -$0.31 vs -$0.17. For the twelve months ended December 31, 2016 vs December 31, 2015, Echelon reported
revenue of $32.4 vs $38.8 (down 16.5%), diluted earnings per share -$0.93 vs -$3.00. Echelon is expected to report earnings on
11/02/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 1
analysts forecasts, the consensus EPS forecast for the quarter is -$0.23. The reported EPS for the same quarter last year was
-$0.29.
To read the full Echelon Corporation (ELON) report, download it here: http://Fundamental-Markets.com/register/?so=ELON
-----------------------------------------
NII HOLDINGS, INC. (NIHD) REPORT OVERVIEW
NII Holdings' Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, NII Holdings reported revenue of $225.1 vs $249.2
(down 9.7%). For the twelve months ended December 31, 2016 vs December 31, 2015, NII Holdings reported revenue of $985.0 vs
$1,213.1 (down 18.8%). NII Holdings is expected to report earnings on 11/13/2017. The report will be for the fiscal Quarter ending
September 2017. According to Zacks Investment Research, based on 1 analysts forecasts, the consensus EPS forecast for the quarter
is -$0.26. The reported EPS for the same quarter last year was -$0.94.
To read the full NII Holdings, Inc. (NIHD) report, download it here: http://Fundamental-Markets.com/register/?so=NIHD
-----------------------------------------
ANI PHARMACEUTICALS, INC. (ANIP) REPORT OVERVIEW
ANI Pharmaceuticals's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, ANI Pharmaceuticals reported revenue of $44.8 vs
$31.3 (up 43.1%), diluted earnings per share $0.23 vs $0.10 (up 130.0%). For the twelve months ended December 31, 2016 vs December
31, 2015, ANI Pharmaceuticals reported revenue of $128.6 vs $76.3 (up 68.6%), diluted earnings per share $0.34 vs $1.32 (down
74.2%). ANI Pharmaceuticals is expected to report earnings on 11/02/2017. The report will be for the fiscal Quarter ending
September 2017. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter
is $0.90. The reported EPS for the same quarter last year was $1.02.
To read the full ANI Pharmaceuticals, Inc. (ANIP) report, download it here: http://Fundamental-Markets.com/register/?so=ANIP
-----------------------------------------
ZION OIL & GAS, INC. (ZN) REPORT OVERVIEW
Zion Oil & Gas's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Zion Oil & Gas reported diluted earnings per share of
-$0.10 vs -$0.08. For the twelve months ended December 31, 2016 vs December 31, 2015, Zion Oil & Gas reported diluted earnings per
share of -$0.21 vs -$0.20.
To read the full Zion Oil & Gas, Inc. (ZN) report, download it here: http://Fundamental-Markets.com/register/?so=ZN
-----------------------------------------
VTV THERAPEUTICS INC. (VTVT) REPORT OVERVIEW
vTv Therapeutics's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, vTv Therapeutics reported revenue of $0.013 vs $0.182
(down 92.9%), diluted earnings per share -$0.41 vs -$0.47. For the twelve months ended December 31, 2016 vs December 31, 2015, vTv
Therapeutics reported revenue of $0.634 vs $0.519 (up 22.2%), diluted earnings per share -$1.71 vs -$3.32. vTv Therapeutics is
expected to report earnings on 11/01/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks
Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.40. The reported EPS for the
same quarter last year was -$0.41.
To read the full vTv Therapeutics Inc. (VTVT) report, download it here: http://Fundamental-Markets.com/register/?so=VTVT
-----------------------------------------
SEARS HOLDINGS CORPORATION (SHLD) REPORT OVERVIEW
Sear Holdings’ Recent Financial Performance
For the three months ended July 29, 2017 vs July 30, 2016, Sear Holdings reported revenue of $4,365 vs $5,663
(down 22.9%), diluted earnings per share -$2.34 vs -$3.70. For the twelve months ended January 28, 2017 vs January 30, 2016, Sear
Holdings reported revenue of $22,138 vs $25,146 (down 12.0%), diluted earnings per share -$20.78 vs -$10.59.
To read the full Sears Holdings Corporation (SHLD) report, download it here: http://Fundamental-Markets.com/register/?so=SHLD
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world’s leading
brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com
© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a
partner network manager at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory
Authority, Inc.
